Soleno Therapeutics (SLNO) Q2 2025 Earnings

7MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.83
-1.41
-0.99
-0.57

Details

Expected EPS
-0.97
Actual EPS
-0.95
Surprise EPS
0.02
Surprise Percent
+2.06%

Description

Soleno Therapeutics (SLNO) has reported earnings of -0.95 per share for Q2 2025.

0 Comments

Share your thoughts